Back
Cadrenal Therapeutics, Inc. 10K Form
Sell
44
CVKD
Cadrenal Therapeutics, Inc.
Last Price:
$9.90
Seasonality Move:
23.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CVKD News And Ratings
See the #1 stock for the next 7 days that we like better than CVKD
CVKD Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.33 |
| Price / Book: | 7.73 |
Profitability
| EPS (TTM): | -8.01440 |
|---|---|
| Net Income (TTM): | $-14.4M |
| Gross Margin: | $-1.9K |
| Return on Equity: | -299.72% |
| Return on Assets: | -219.15% |
Cadrenal Therapeutics, Inc. Earnings Forecast
Key Cadrenal Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 3 years have been positive in 1 years.
Cadrenal Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CVKD |
| Website: | cadrenal.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.95 |
| Quick Ratio: | 2.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CVKD Technical Analysis vs Fundamental Analysis
Sell
44
Cadrenal Therapeutics, Inc. (CVKD)
is a Sell
Is Cadrenal Therapeutics, Inc. a Buy or a Sell?
-
Cadrenal Therapeutics, Inc. stock is rated a SellThe current Cadrenal Therapeutics, Inc. [CVKD] share price is $10.18. The Score for CVKD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.